L&C BIO Co.,LTD (KOSDAQ:290650)
63,200
+600 (0.96%)
May 21, 2026, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.56 trillion as of May 20, 2026. Its market cap has increased by 228.07% in one year.
Market Cap
1.56T
Enterprise Value
1.62T
Revenue
85.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
63,200.00
Market Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.56T, an increase of 697.80%. That is a compound annual growth rate of 31.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 1.56T | 3.40% |
| Dec 30, 2025 | 1.50T | 175.14% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seegene | 1.38T |
| SEERS | 1.33T |
| WON TECH | 658.42B |
| ToolGen | 633.89B |
| InBody Co.,Ltd | 578.21B |
| Curexo | 511.62B |
| i-SENS | 506.69B |
| Bio Plus | 315.09B |